Company profile: CN Bio
1.1 - Company Overview
Company description
- Provider of human organ-on-a-chip platforms and services for drug discovery and disease research, including PhysioMimix OOC single- and multi-organ systems, PhysioMimix HT for higher-throughput R&D, contract research services, and liver and lung assays covering NASH, HBV, and COVID-19 for long-term culture, infection modeling, drug efficacy, safety testing, and immune response studies.
Products and services
- PhysioMimix OOC Systems: Microphysiological-scale platforms that model human biology for drug discovery, offering single- and multi-organ capabilities to test therapeutics in human-relevant contexts
- PhysioMimix HBV Assay: Long-term-culture-capable liver-on-a-chip model of hepatitis B infection enabling evaluation of anti-HBV drugs across the full viral lifecycle
- PhysioMimix HT: Higher-throughput organ-on-a-chip system engineered to address adoption barriers and enhance R&D workflows for drug discovery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CN Bio
Lextox
HQ: United Kingdom
Website
- Description: Provider of hair drug and alcohol, blood alcohol, DNA, and SCRAM continuous alcohol testing for family law cases and child care proceedings. Operates a hair drug and alcohol testing laboratory and is a member of the SYNLAB Group. Customers can contact via phone, mail, and social media.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lextox company profile →
VUV Analytics
HQ: United States
Website
- Description: Provider of vacuum ultraviolet optical technologies for use in the life and environmental sciences.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VUV Analytics company profile →
Fluidic
HQ: United Kingdom
Website
- Description: Provider of tools for protein characterization, designing, developing and manufacturing instruments based on Microfluidic Diffusional Sizing (MDS) to analyze protein interactions in their native conditions without immobilization, delivering data on affinity, size and concentration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fluidic company profile →
SkinBioTherapeutics
HQ: United Kingdom
Website
- Description: Provider of probiotic bacteria lysate-based skin technologies and products, including the SkinBiotix platform to improve skin barrier integrity, repair and reduce bacterial load; AxisBiotix-Ps probiotic supplement for psoriasis; cosmetic skincare for sensitive skin and anti-aging; food supplements for eczema, psoriasis and acne; medical skin care and infection control solutions for hospital and domestic settings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SkinBioTherapeutics company profile →
ReadyCell
HQ: Spain
Website
- Description: Provider of cell-based in vitro tools and drug discovery services, including: CacoReady, a ready-to-use Caco-2 kit for assessing intestinal permeability in preclinical studies; CacoGoblet, a Caco-2/HT-29 co-culture to evaluate intestinal absorption and anti-inflammatory drug efficacy; PreadyPort, MDCKII-based kits to study permeability and MDR1/BCRP efflux; PreadyTake, HEK293 transporter-overexpressing kits (MATE1, OCT2, OATP1B3).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ReadyCell company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CN Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CN Bio
2.2 - Growth funds investing in similar companies to CN Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CN Bio
4.2 - Public trading comparable groups for CN Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →